These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1149 related items for PubMed ID: 21900088

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Letter by Bernstein et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
    Bernstein RA, Alberts MJ, Garcia DA.
    Circulation; 2012 Apr 24; 125(16):e614; author reply e616. PubMed ID: 22529072
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers.
    Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.
    Thromb Haemost; 2012 Aug 24; 108(2):217-24. PubMed ID: 22627883
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban.
    Dinkelaar J, Molenaar PJ, Ninivaggi M, de Laat B, Brinkman HJ, Leyte A.
    J Thromb Haemost; 2013 Jun 24; 11(6):1111-8. PubMed ID: 23578206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity.
    Graff J, von Hentig N, Misselwitz F, Kubitza D, Becka M, Breddin HK, Harder S.
    J Clin Pharmacol; 2007 Nov 24; 47(11):1398-407. PubMed ID: 17873238
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate.
    Hoffman M, Volovyk Z, Monroe DM.
    Anesthesiology; 2015 Feb 24; 122(2):353-62. PubMed ID: 25502064
    [Abstract] [Full Text] [Related]

  • 15. Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban.
    Herrmann R, Thom J, Wood A, Phillips M, Muhammad S, Baker R.
    Thromb Haemost; 2014 May 05; 111(5):989-95. PubMed ID: 24352511
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
    Dinkelaar J, Patiwael S, Harenberg J, Leyte A, Brinkman HJ.
    Clin Chem Lab Med; 2014 Nov 05; 52(11):1615-23. PubMed ID: 24902009
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model.
    Godier A, Miclot A, Le Bonniec B, Durand M, Fischer AM, Emmerich J, Marchand-Leroux C, Lecompte T, Samama CM.
    Anesthesiology; 2012 Jan 05; 116(1):94-102. PubMed ID: 22042412
    [Abstract] [Full Text] [Related]

  • 20. Bleeding and antidotes in new oral anticoagulants.
    Majeed A, Schulman S.
    Best Pract Res Clin Haematol; 2013 Jun 05; 26(2):191-202. PubMed ID: 23953907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.